Please login to the form below

Not currently logged in
Email:
Password:

Bind Therapeutics

This page shows the latest Bind Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Pfizer set to snap up Bind’s assets for $20m

Pfizer set to snap up Bind’s assets for $20m

Pfizer set to snap up Bind’ s assets for $20m. Biotech approves 'stalking horse' bid from the pharma giant. ... Nano-engineering firm Bind Therapeutics has reached a $20m agreement with Pfizer for the purchase of the majority of its assets.

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Fostering partnerships. Recent developments include agreements to license the WEE1 inhibitor MK-1775 from Merck &Co and a collaboration with Bind Therapeutics which puts a molecule discovered by AZ – an Aurora

  • Deal Watch table for April 2013 Deal Watch table for April 2013

    Award. Smallpox vaccine research. 228. Bind Therapeutics/ Pfizer. Collaboration. Employ the Medicinal Nanoengineering platform to develop and commercialise Accurins. ... 200. Bind Therapeutics/ AstraZeneca. Collaboration. Employ the Medicinal

  • Pharma deals during April 2013 Pharma deals during April 2013

    Being bound to Bind– a popular choice. Bind Therapeutics did particularly well as a result of the frenzy, signing global deals with Pfizer and AstraZeneca (AZ), both based on Bind's ... This similarly weighted deal could net Bind more than $180.5m plus

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • BIND Therapeutics appoints Andrew Hirsch as permanent CEO BIND Therapeutics appoints Andrew Hirsch as permanent CEO

    BIND Therapeutics appoints Andrew Hirsch as permanent CEO. He had held the role on an interim basis since March. ... Nanomedicine company BIND Therapeutics has appointed Andrew Hirsch as president and chief executive, confirming him in the roles he has

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics